Enhancing antibody detection sensitivity in lateral flow immunoassays using endospores of Bacillus subtilis as signal amplifiers.

Enhancing antibody detection sensitivity in lateral flow immunoassays using endospores of Bacillus subtilis as signal amplifiers.

Publication date: Aug 15, 2024

Antibody detection is the critical first step for tracking the spread of many diseases including COVID-19. Lateral flow immunoassay (LFIA) is the most commonly used method for rapid antibody detection because it is easy-to-use and inexpensive. However, LFIA has limited sensitivity when gold nanoparticles (AuNPs) are used as the signals. In this study, the endospores of Bacillus subtilis were used in combination with AuNP in a LFIA to detect antibodies. The endospores serve as a signal amplifier. The detection limit was about 10 M for anti-beta galactosidase antibody detection whereas the detection limit of conventional LFIA is about 10 M. Furthermore, the proposed methods have no additional user steps compared with the traditional LFIA. This method, therefore, improved the sensitivity 100-fold without compromising any advantages of LFIA. We believe that the proposed method will be useful for detection of antibodies against HIV, Zika virus, SARS-CoV-2, and so on.

Concepts Keywords
10m Antibodies, Viral
Amplifiers Antibodies, Viral
Antibody Antibody detection
Hiv Bacillus subtilis
Inexpensive Bacillus subtilis
COVID-19
Endospores
Gold
Gold
Gold nanoparticles
Humans
Immunoassay
Lateral flow immunoassays
Limit of Detection
Metal Nanoparticles
SARS-CoV-2
Spores, Bacterial
Zika Virus

Semantics

Type Source Name
drug DRUGBANK Gold
disease MESH COVID-19

Original Article

(Visited 2 times, 1 visits today)